Go Pro

Kendall Capital Management Buys Shares of 11,622 Adtalem Global Education Inc. $CVSA

Key Points

  • Kendall Capital Management initiated a position in Adtalem Global Education, buying 11,622 shares worth approximately $1.45 million during the second quarter.
  • Adtalem reported quarterly EPS of $2.09, beating analysts’ $1.90 consensus, on revenue of $501.38 million. The company issued fiscal 2027 EPS guidance of $8.90–$9.15.
  • Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $155, although insiders sold 25,951 shares worth about $3.47 million over the last quarter.
  • Five stocks to consider instead of Adtalem Global Education.

Kendall Capital Management purchased a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,622 shares of the company's stock, valued at approximately $1,449,000.

More Adtalem Global Education News

Here are the key news stories impacting Adtalem Global Education this week:

  • Positive Sentiment: Zacks Research introduced a FY2029 EPS estimate of $11.53, indicating expected earnings growth from its $8.99 current-year consensus estimate. Its FY2028 forecast of $9.94 also remains above the current-year outlook.
  • Neutral Sentiment: The revisions came from Zacks Research and do not represent a change to the broader consensus estimate for Adtalem’s current fiscal year, which remains $8.99 per share.
  • Negative Sentiment: Zacks reduced EPS forecasts across multiple periods: Q1 2027 to $1.97 from $2.00, Q2 2027 to $2.38 from $2.51, Q4 2027 to $2.28 from $2.29, Q1 2028 to $2.30 from $2.33, Q2 2028 to $2.56 from $2.68, Q3 2028 to $2.50 from $2.53, and Q4 2028 to $2.59 from $2.63. Zacks also lowered its FY2028 forecast to $9.94 from $10.16, signaling somewhat softer projected profitability.

Insider Buying and Selling

In other Adtalem Global Education news, CEO Stephen W. Beard sold 3,545 shares of Adtalem Global Education stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $130.34, for a total value of $462,055.30. Following the transaction, the chief executive officer owned 415,197 shares in the company, valued at $54,116,776.98. This trade represents a 0.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 4,526 shares of the business's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.81, for a total transaction of $614,676.06. Following the sale, the senior vice president directly owned 28,544 shares of the company's stock, valued at $3,876,560.64. This represents a 13.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 25,951 shares of company stock valued at $3,470,783. Insiders own 2.50% of the company's stock.

Adtalem Global Education Trading Up 3.5%

Adtalem Global Education stock opened at $132.55 on Friday. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of 18.83, a P/E/G ratio of 0.98 and a beta of 0.62. The firm has a fifty day simple moving average of $125.54. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, equities analysts predict that Adtalem Global Education Inc. will post 9 EPS for the current year.

Analyst Ratings Changes

CVSA has been the topic of a number of analyst reports. Wall Street Zen raised Adtalem Global Education from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Truist Financial boosted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, May 11th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Adtalem Global Education in a research note on Wednesday. Finally, Barrington Research reiterated an "outperform" rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Adtalem Global Education has a consensus rating of "Moderate Buy" and an average target price of $155.00.

Check Out Our Latest Stock Report on Adtalem Global Education

About Adtalem Global Education

(Free Report)

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

Featured Stories

Want to see what other hedge funds are holding CVSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adtalem Global Education Inc. (NYSE:CVSA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Adtalem Global Education Right Now?

Before you consider Adtalem Global Education, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adtalem Global Education wasn't on the list.

While Adtalem Global Education currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines